GSK's Buyback, Upgraded Guidance Boost FTSE 100

3 days ago · GSK's Buyback, Upgraded Guidance Boost FTSE 100 12:01pm: MT GSK, gold miners shares push Britain's FTSE 100 higher 12:00pm: RE FTSE 100 edges up, gold gleams …

CouponFollow Extension

54%
OFF

GSK's Buyback, Upgraded Guidance Boost FTSE 100

2 weeks from now

3 days ago · The UK's FTSE 100 ended Wednesday's trading session 0.54% higher, led by GSK GSK after the pharmaceutical giant raised its long-term growth outlook and announced a new …

tradingview.com

1%
OFF

London Midday: Stocks Slightly Higher; GSK Jumps On Guidance …

2 weeks from now

3 days ago · The FTSE 100 was up 0.1% at 8,582.59. Russ Mould, investment director at AJ Bell , said: "A sense of calm returned to markets after the tariff-related tantrum.

lse.co.uk

54%
OFF

GSK's Buyback, Upgraded Guidance Boost FTSE 100

2 weeks from now

3 days ago · The UK's FTSE 100 ended Wednesday's trading session 0.54% higher, led by GSK after the pharmaceutical giant raised its long-term growth outlook and announced a new share …

marketscreener.com

26%
OFF

FTSE 100 Live Wednesday - Yahoo Finance

2 weeks from now

3 days ago · FTSE 100 Live Wednesday. GSK lifts sales outlook. Car registrations down last month. SSE renewables output up 26%. Market update: GSK guidance boosts shares, …

yahoo.com

$2
OFF

GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …

2 weeks from now

3 days ago · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …

investopedia.com

£2
OFF

GSK Launches £2bn Share Buyback And Upgrades Sales Forecast

2 weeks from now

3 days ago · Strong growth in HIV, oncology and specialty medicines have offset a 4 per cent decline in vaccine sales

thetimes.com

£20
OFF

FTSE 100 Shares Round-up: Next, GSK, Haleon, LSE, Smith & Nephew

2 weeks from now

Aug 1, 2024 · Alongside Rolls-Royce Holdings (LSE:RR.), Next lit up the FTSE 100 after a £20 million boost to full-year profits guidance to £980 million helped shares add another 784p to a …

ii.co.uk

11%
OFF

Ii View: Negative Reaction To GSK's Guidance Upgrade - Interactive …

2 weeks from now

Jul 31, 2024 · ii view: negative reaction to GSK's guidance upgrade. Shares in this FTSE 100 drug major are down 11% over the last five years, underperforming a near 13% gain for the index. …

ii.co.uk

5%
OFF

UK's FTSE 100 Sees Gains Thanks To GSK's Settlement Deal

2 weeks from now

This positive news gave the pharmaceuticals and biotech index a 1.5% boost, highlighting the sector's strong performance. Meanwhile, other factors contributed to the FTSE 100's rise: the …

finimize.com

6%
OFF

FTSE Gains Amid Investor Optimism And GSK's Surge

2 weeks from now

3 days ago · The FTSE 100 rose by 0.6%, propelled by surges in GSK and gold mining shares, as market focus shifted toward the Bank of England's upcoming rate decision. GSK soared 7.6% …

devdiscourse.com

1%
OFF

London Open: FTSE Nudges Up; GSK Surges On Guidance Upgrade

2 weeks from now

3 days ago · At 0830 GMT, the FTSE 100 was up 0.1% at 8,577.75. Kathleen Brooks, research director at XTB , said: "Risk appetite continues to dwindle this week and European shares …

lse.co.uk

FAQs about GSK's Buyback, Upgraded Guidance Boost FTSE 100 Coupon?

Why did GSK dominate FTSE 100 today?

GSK dominated a steady FTSE 100 index today after the drugs giant’s long-term guidance helped to revitalise shares following their dismal showing in 2024. The blue-chip rallied 5% or 76.5p to 1456.5p as investors also cheered plans for an increased 2025 dividend and a £2 billion buyback of shares. ...

Does the Motley Fool recommend GSK plc?

The Motley Fool UK has recommended GSK plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. ...

Will GSK's separation lead to faster growth rates?

It’s been a dramatic year for FTSE 100 pharmaceutical group GSK ( LSE: GSK ). Over the summer, GSK completed the long-awaited separation of its consumer healthcare business. Investors (including me) were bullish about the new GSK. I reckoned the group’s tightened focus and reduced debt levels would lead to faster growth rates. ...

Are GSK shares worth £9bn less than they were before?

GSK disputes the claims, but the market is worried. GSK shares are worth £9bn less than they were before the claims emerged in August. For long-term investors like me, there’s a choice to be made here. Do I take advantage of GSK’s reduced share price and hope to lock in an attractive long-term return? ...

How much will GSK sell in 2031?

GSK is now targeting 2031 sales of more than £40 billion, up from its previous guidance of £38 billion amid stronger progress in its late-stage drugs pipeline. Total 2024 sales in today’s annual results were 3% higher at £31.4 billion, or 7% at constant exchange rates. ...

How did GSK's sales perform in September?

GSK’s sales rose by 9% to £7.8bn during the three months to September. Adjusted profits climbed 4% higher to £2.6bn. This growth was helped by sales of shingles vaccine Shingrix, as well as specialty medicines in areas such as cancer and immunology. These numbers suggest to me that demand for the company’s proprietary medicines is healthy. ...